Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lin Shen

Showing results (1381-1390 of 1,553) with videos related to

Pageof 156
Sort By:
Journal for Immunotherapy of Cancer|January 5, 2024
Non-invasive CT imaging biomarker to predict immunotherapy response in gastric cancer: a multicenter studyWeicai Huang, Wenjun Xiong, Lei Tang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 8, 2024
Effectiveness of Endoscopic Screening on Esophageal Cancer Incidence and Mortality: A 9-Year Report of the Endoscopic Screening for Esophageal Cancer in China (ESECC) Randomized TrialMengfei Liu, Wenlei Yang, Chuanhai Guo, et al.
ACS Nano|May 26, 2011
Fluorescent gold nanoclusters as a biocompatible marker for in vitro and in vivo tracking of endothelial cellsHsueh-Hsiao Wang, Cheng-An J Lin, Chih-Hsien Lee, et al.
Signal Transduction and Targeted Therapy|June 27, 2024
Clinical efficacy and identification of factors confer resistance to afatinib (tyrosine kinase inhibitor) in EGFR-overexpressing esophageal squamous cell carcinomaYanni Wang, Chang Liu, Huan Chen, et al.
The Journal of Pathology|May 25, 2022
Absence of NOTCH1 mutation and presence of CDKN2A deletion predict progression of esophageal lesionsMengfei Liu, Ying Liu, Ren Zhou, et al.
JAMA|February 24, 2025
First-Line Sugemalimab Plus Chemotherapy for Advanced Gastric Cancer: The GEMSTONE-303 Randomized Clinical TrialXiaotian Zhang, Jufeng Wang, Gang Wang, et al.
Japanese Journal of Clinical Oncology|August 12, 2025
Tasurgratinib (E7090) for cholangiocarcinoma with fibroblast growth factor receptor 2 fusions/rearrangements: a multicenter, open-label, Phase 2 studyLin Shen, Huaxin Duan, Takamichi Kuwahara, et al.
Mbio|October 7, 2025
Gut microbiota dysbiosis and metabolic perturbations of bile/glyceric acids in major depressive disorder with IBS comorbidityJia-Yu Du, Zhen-Jie Zhang, Li Tan, et al.
Archives of Osteoporosis|July 28, 2022
Efficacy of generic teriparatide and alendronate in Chinese postmenopausal women with osteoporosis: a prospective studyMei Li, Zhenlin Zhang, Qingyun Xue, et al.
Neurobiology of Disease|August 9, 2019
Neurotrophin receptor p75 mediates amyloid β-induced tau pathologyLin-Lin Shen, Wei-Wei Li, Ya-Li Xu, et al.
Pageof 156

Showing results (1381-1390 of 1,553) with videos related to

Sort By:
Pageof 156
Journal for Immunotherapy of Cancer|January 5, 2024
Non-invasive CT imaging biomarker to predict immunotherapy response in gastric cancer: a multicenter studyWeicai Huang, Wenjun Xiong, Lei Tang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 8, 2024
Effectiveness of Endoscopic Screening on Esophageal Cancer Incidence and Mortality: A 9-Year Report of the Endoscopic Screening for Esophageal Cancer in China (ESECC) Randomized TrialMengfei Liu, Wenlei Yang, Chuanhai Guo, et al.
ACS Nano|May 26, 2011
Fluorescent gold nanoclusters as a biocompatible marker for in vitro and in vivo tracking of endothelial cellsHsueh-Hsiao Wang, Cheng-An J Lin, Chih-Hsien Lee, et al.
Signal Transduction and Targeted Therapy|June 27, 2024
Clinical efficacy and identification of factors confer resistance to afatinib (tyrosine kinase inhibitor) in EGFR-overexpressing esophageal squamous cell carcinomaYanni Wang, Chang Liu, Huan Chen, et al.
The Journal of Pathology|May 25, 2022
Absence of NOTCH1 mutation and presence of CDKN2A deletion predict progression of esophageal lesionsMengfei Liu, Ying Liu, Ren Zhou, et al.
JAMA|February 24, 2025
First-Line Sugemalimab Plus Chemotherapy for Advanced Gastric Cancer: The GEMSTONE-303 Randomized Clinical TrialXiaotian Zhang, Jufeng Wang, Gang Wang, et al.
Japanese Journal of Clinical Oncology|August 12, 2025
Tasurgratinib (E7090) for cholangiocarcinoma with fibroblast growth factor receptor 2 fusions/rearrangements: a multicenter, open-label, Phase 2 studyLin Shen, Huaxin Duan, Takamichi Kuwahara, et al.
Mbio|October 7, 2025
Gut microbiota dysbiosis and metabolic perturbations of bile/glyceric acids in major depressive disorder with IBS comorbidityJia-Yu Du, Zhen-Jie Zhang, Li Tan, et al.
Archives of Osteoporosis|July 28, 2022
Efficacy of generic teriparatide and alendronate in Chinese postmenopausal women with osteoporosis: a prospective studyMei Li, Zhenlin Zhang, Qingyun Xue, et al.
Neurobiology of Disease|August 9, 2019
Neurotrophin receptor p75 mediates amyloid β-induced tau pathologyLin-Lin Shen, Wei-Wei Li, Ya-Li Xu, et al.
Pageof 156